Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
The New England Journal of Medicine|March 9, 2012
Donepezil and memantine for moderate-to-severe Alzheimer's diseaseRobert Howard, Rupert McShane, James Lindesay, et al.
Trials|July 28, 2009
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCTRob Jones, Bart Sheehan, Patrick Phillips, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 14, 2019
Assessment of need and practice for assistive technology and telecare for people with dementia-The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trialKirsty Forsyth, Catherine Henderson, Lucy Davis, et al.
The Journal of Prevention of Alzheimer'S Disease|April 18, 2026
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control dataBjoern O Schelter, Helen Shiells, Serena Lo, et al.
Age and Ageing|November 16, 2020
Mild cognitive impairment: the Manchester consensusRoss A Dunne, Dag Aarsland, John T O'Brien, et al.
Plos One|June 30, 2017
Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendationsLucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
The Journal of Prevention of Alzheimer'S Disease|January 22, 2026
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's diseaseClaude M Wischik, Richard Stefanacci, Peter Bentham, et al.
Health Technology Assessment (Winchester, England)|June 20, 2017
Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendationsLucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Metabolomics : Official Journal of the Metabolomic Society|January 20, 2015
Molecular phenotyping of a UK population: defining the human serum metabolomeWarwick B Dunn, Wanchang Lin, David Broadhurst, et al.
International Journal of Geriatric Psychiatry|October 29, 2019
Pathways to care for people with dementia: An international multicentre studyUmberto Volpe, Hania Amin, Olatunde O Ayinde, et al.
Pageof 17